IL15 and neoplasm: As shown in Fig. 4B, C and Additional file 1: Fig. S3B, compared with control mice with a rapid progression of tumor development, mice treated with CD19-CAR-IL-15 T cells and CD19-CAR-IL-15-IL-15Ra T cells showed no tumor development, implying enhanced anti-tumor activity induced by IL-15.